Description
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Product Unit Size | Cost | Quantity | Stock |
|---|
This compound is a derivative of methyl caffeate, a hydroxycinnamic acid; it exhibits chemopreventive potential, inhibiting the development of colon tumors in vivo.
| Purity | ≥98% |
|---|---|
| Formula | C18H18O4 |
| Formula Wt. | 298.33 |
| IUPAC Name | 2-phenylethyl 3-(3-hydroxy-4-methoxyphenyl)propanoate |
| Appearance | White Crystal Powder |
| Store Temp | 4°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet |
Pereira MA. Prevention of colon cancer and modulation of aberrant crypt foci, cell proliferation, and apoptosis by retinoids and NSAIDs. Adv Exp Med Biol. 1999;470:55-63. PMID: 10709674.
Labdane diterpene found in Andrographis.
Imidazole; 14-α demethylase inhibitor.
Selective 5-HT6 receptor antagonist
Nitroimidazole; hypoxic modifier and radiosensi...
Taxane synthesis intermediate.
Mycotoxin metabolite
Geldanamycin derivative; HSP90 inhibitor.
Found in Aristolochia and Radix; potential PLA2...
Allosteric inhibitor
Polyene macrolide, induces pore formation in fu...
Anthracycline, DNA intercalator; topoisomerase ...
Long-chain 3-ketoacyl-CoA thiolase inhibitor, p...
Calcium channel blocker.
Wortmannin analog; PI3K inhibitor.
Type A trichothecene mycotoxin produced by Fusa...
NSAID; COX-2 inhibitor.
Cholesterol ester transfer protein inhibitor.
NMDA potentiator, GABA-A antagonist.
Sulfonamide; folate production inhibitor.